Table 4

The individual components of MACE and clinical outcomes at 24 months

Provisional side branch stenting (Simple)Two-stent technique (Complex)Risk difference
(95% CI)
P value
Events at 6monthsFollow-up in 220 patientsFollow-up in 228 patients
MACE12 (5.5%)5 (2.2%)3.2% (−0.2 to 6.8)0.07
All-cause mortality0 (0%)1 (0.4%)−0.4% (−1.3 to 0.4)0.33
Cardiac mortality0 (0%)0 (0%)0.0% (0.0 to 0.0)1.00
Myocardial infarction*6 (2.7%)3 (1.3%)1.4% (−1.2 to 4.0)0.29
Target-lesion revascularisation9 (4.1%)4 (1.8%)2.3% (−0.8 to 5.5)0.14
Target-vessel revascularisation10 (4.6%)4 (1.8%)2.8% (−0.4 to 6.0)0.11
Definite stent thrombosis2 (0.9%)2 (0.9%)0.0% (−1.7 to 1.8)0.97
Events at 24 months†Follow-up in 218 patientsFollow-up in 228 patientsHR(95% CI)P value
MACE12.9% (28)8.4% (19)0.63 (0.35 to 1.13)0.12
All-cause mortality2.3% (5)2.2% (5)0.94 (0.28 to 3.31)0.94
Cardiac mortality0.9% (2)0.9% (2)0.96 (0.13 to 6.8)0.96
Myocardial infarction*5.1% (11)3.1% (7)0.60 (0.23 to 1.55)0.30
Target-lesion revascularisation9.2% (20)6.2% (14)0.66 (0.33 to 1.30)0.23
Target-vessel revascularisation10.5% (23)6.6% (15)0.61 (0.32 to 1.17)0.13
Risk difference (95% CI)
CCS class ≥2 angina‡8 (3.9%)9 (4.1%)−0.2% (−4.0 to 3.4)0.89
Stent thrombosis‡
 Definite, any (0–2 years)3 (1.4%)3 (1.3%)0.1% (−2.0 to 2.2)0.96
 Definite, acute (0–1 day)1 (0.5%)1 (0.4%)0.0% (−1.2 to 1.3)0.98
 Definite, subacute (2–30 days)1 (0.5%)1 (0.4%)0.0% (−1.2 to 1.3)0.98
 Definite, late (1–12 months)0 (0.0%)0 (0.0%)0.0% (0.0 to 0.0)
 Definite, very late (12–24 months)1 (0.5%)1 (0.4%)0.0% (−1.2 to 1.3)0.98
 Definite or probable, any (0–2 years)4 (1.8%)3 (1.3%)0.5% (−1.7 to 2.8)0.66
 Definite, prob. or poss., any (0–2 years)6 (2.8%)5 (2.2%)0.6% (−2.3 to 3.4)0.70
  • *Non-procedure related. Values are n (%).

  • †Twenty-four month results are given as Kaplan-Meier estimates and (n).

  • ‡Results are given as n (%), risk difference and 95% CI.

  • MACE, major adverse cardiac events .